Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2026-03-01 @ 12:06 PM
Study NCT ID:
NCT05105412
Status:
TERMINATED
Last Update Posted:
2024-07-08
First Post:
2021-10-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas
Sponsor:
National Health Research Institutes, Taiwan
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
T1421
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None